HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Gehrke Selected Research

EC 0489

2/2011Reducing undesirable hepatic clearance of a tumor-targeted vinca alkaloid via novel saccharopeptidic modifications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Gehrke Research Topics

Disease

1Constipation
02/2011
1Neoplasms (Cancer)
02/2011

Drug/Important Bio-Agent (IBA)

1EC145IBA
02/2011
1EC 0489IBA
02/2011
1AlkaloidsIBA
02/2011
1Folic Acid (Vitamin M)FDA LinkGeneric
02/2011